Publications

Loukovaara S, Gucciardo E, Korhonen A, Öhman T, Kauppinen A.

Askeleita kohti verkkokalvon irtauman jälkeisen arven lääkkeellistä estoa. Duodecim 2022;138(5):408-18

  • Korhonen A, Gucciardo E, Lehti K, Loukovaara S. Phosphodiesterase type 5 inhibitor (sildenafil) - impact in proliferative diabetic retinopathy? Acta Ophthalmol. 2021 Nov 8.
  • Korhonen A, Gucciardo E, Lehti K, Loukovaara S. Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement. Sci Rep 2021; 11, 18810.
  • Pietilä EA, Gonzalez-Molina J, Moyano-Galceran L, Jamalzadeh S, Zhang K, Lehtinen L, Turunen SP, Martins TA, Gultekin O, Lamminen T, Kaipio K, Joneborg U, Hynninen J, Hietanen S, Grénman S, Lehtonen R, Hautaniemi S, Carpén O, Carlson JW, Lehti K. Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance. Nat Commun. 2021 Jun 23;12(1):3904.
  • Mysore Y, Del Amo EM, Loukovaara S, Hagström M, Urtti A, Kauppinen A. Statins for the prevention of proliferative vitreoretinopathy: cellular responses in cultured cells and clinical statin concentrations in the vitreous. Sci Rep 2021 Jan 13;11(1):980.
  • Öhman T, Gawriyski L, Miettinen S, Varjosalo M, Loukovaara S. Molecular pathogenesis of rhegmatogenous retinal detachment. Sci Rep. 2021 Jan 13;11(1):966.
  • Gucciardo E, Lehti TA, Korhonen A, Salvén P, Lehti K*, Jeltsch M*, Loukovaara S*. Imusuonet ja silmä. Duodecim 2020;135(16):1777-88.
  • Moyano-Galceran L, Pietilä EA , Turunen SP, Corvigno S, Hjerpe E, Bulanova D, Joneborg U, Alkasalias T, Miki Y, Yashiro M, Chernenko A, Jukonen J, Singh M, Dahlstrand H, Carlson JW, Lehti L. Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer. EMBO Mol Med. 2020;12(4):e11177. doi: 10.15252/emmm.201911177.
  • Yadav L, Pietilä E, Öhman T, Liu X, Mahato AK, Sidorova Y, Lehti L, Saarma M, Varjosalo M. PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential. iScience 2020;23(2):100871. doi: 10.1016/j.isci.2020.100871.
  • Kasurinen A, Gramolelli S, Hagström J, Laitinen A, Kokkola A, Miki Y, Lehti K, Yashiro M, Ojala PM, Böckelman C, Haglund C. High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1. Cancer Med. 2019;8(16):6995-7005. doi: 10.1002/cam4.2576.
  • Gonzalez-Molina J, Gramolelli S, Liao Z, Carlson JW, Ojala PM, Lehti L. MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues. Review Cells 2019;8(9):991. doi: 10.3390/cells8090991.